Answers are grounded in this paper and cite their sources.
Review reveals distinct organ-specific metabolic and microenvironmental adaptations in metastatic breast cancer, highlighting novel niche-directed therapeutic targets.
Metastasis remains the primary cause of breast cancer death, driven by organotropism to brain, lung, bone, and lymph nodes. Single-cell and spatial multi-omics reveal organotropism as an active ecological process orchestrated by crosstalk between tumor cells and stromal/immune compartments. We synthesize advances into a unified framework: conserved programs (hypoxic memory, stemness, immune evasion) operate alongside organ-specific adaptations—lipid rewiring via RARRES2-PTEN-mTOR in brain, DLAT-mediated fatty acid oxidation in lung, TDO2 + fibroblast-kynurenine ferroptosis resistance in lung, IL-34-CSF1R-ARG1 + macrophage immunosuppression in brain, and MAF-CD248 dormancy in bone. These vulnerabilities inform therapies: dual-payload ADCs, metabolic blockers, and engineered EVs. We address limitations such as spatial mapping, dormancy models, translation and outline a roadmap with AI, liquid biopsies, and spatial profiling for precision interception. This Review advocates shifting from cytotoxic to niche-directed therapies, framing metastasis as an ecosystem challenge.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: